| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/23/2004 | WO2004049917A3 Methods of therapy and diagnosis using targeting of cells that express ly-9 |
| 12/23/2004 | WO2004047754A3 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 12/23/2004 | WO2004045499A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 12/23/2004 | WO2004041213A3 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 12/23/2004 | WO2004040003A3 Nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 12/23/2004 | WO2004025569A3 Tissue image analysis for cell classification and laser capture microdissection |
| 12/23/2004 | WO2004024182A3 Method for isolating hepatitis c virus peptides |
| 12/23/2004 | WO2004019035A9 Method for characterizing biomolecules utilizing a result driven strategy |
| 12/23/2004 | WO2004011910A3 Agent for detecting malondialdehyde, method of making the same, and test kit for use thereof |
| 12/23/2004 | WO2004005479A3 A high resolution typing system for pathogenic borrelia |
| 12/23/2004 | WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/23/2004 | WO2003101497A8 Knockout mice and their use |
| 12/23/2004 | WO2003089898A3 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke |
| 12/23/2004 | WO2003083436A3 Fibrinogen binding moieties |
| 12/23/2004 | WO2003069343A3 Method for the detection of tumor markers cea, ca19.9, or ca72.4 in the stool, allowing diagnosis of gastrointestinal tumors |
| 12/23/2004 | WO2003063679A8 Hepatitis e virus clones and methods of their use |
| 12/23/2004 | WO2003037167A3 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor |
| 12/23/2004 | WO2003021221A3 Method for discovering new infectious particles |
| 12/23/2004 | WO2002095356A3 Methods and compositions for analyzing proteins |
| 12/23/2004 | WO2002077013A3 Human secreted proteins |
| 12/23/2004 | WO2002074240A3 Anti-amyloid antibody based diagnosis and treatment of a neurological disease or disorder |
| 12/23/2004 | US20040260721 Methods and systems for creation of a coherence database |
| 12/23/2004 | US20040260524 Human-clothing-environment simulator |
| 12/23/2004 | US20040260511 System and method for determining an abused sensor during analyte measurement |
| 12/23/2004 | US20040260497 Downhole PV tests for bubble point pressure |
| 12/23/2004 | US20040260479 Computer software program for graphically displaying genetic linkage disequilibrium, and the method thereof |
| 12/23/2004 | US20040260477 Regulatory classification system |
| 12/23/2004 | US20040260165 Blood sugar level measuring apparatus |
| 12/23/2004 | US20040260079 Cardiac-cell specific enhancer elements and uses thereof |
| 12/23/2004 | US20040260072 Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis |
| 12/23/2004 | US20040260071 Benzophene-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor crf binding protein |
| 12/23/2004 | US20040259853 Atherosclerosis; cardiovascular disorders; anticholesterol agents; administering an amphilic compound which prevents transferring of cholesterol |
| 12/23/2004 | US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay |
| 12/23/2004 | US20040259810 Porphyrin derivatives for photodynamic therapy |
| 12/23/2004 | US20040259797 peptide mixture; induce immunology response; gag protein; vaccines |
| 12/23/2004 | US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents |
| 12/23/2004 | US20040259793 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 12/23/2004 | US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents |
| 12/23/2004 | US20040259776 Screening for apoptosis |
| 12/23/2004 | US20040259770 Measurement strength of lactoferrin in soluble or immobilized form; contacting cell containing leukocyte; activation |
| 12/23/2004 | US20040259764 Reticulocyte depletion signatures |
| 12/23/2004 | US20040259272 Fixed support for immobilizing biomolecules |
| 12/23/2004 | US20040259270 System, device and method for exciting a sensor and detecting analyte |
| 12/23/2004 | US20040259269 Method for detection of molecular species in a crude sample using capillary electrophoresis |
| 12/23/2004 | US20040259265 for concentrating and separating fluid samples at pressures up to about 10,000 psi; concentrator and separator may consist of solid-state thin-film heater-adsorber and channel supported by solid substrate; concentrator has heated interactive elements for adsorbing constituents of sample; portable |
| 12/23/2004 | US20040259264 Method And Apparatus FOr Measuring Specific Component |
| 12/23/2004 | US20040259263 of nucleic acids, with X-rays at an intensity less than 109 photons sec-1 mm-2, and for an amount of time less than 1,000 msec; produces hydroxy radicals; footprinting a nucleic acid |
| 12/23/2004 | US20040259262 using reagent lumogallion to chelate aluminum in a sample and detecting aluminum chelate with a fluorescent detector; chromatography; for pharmaceutical samples containing vitamin B2 for example, as aluminum chelate and vitamin B2 have distinct signals |
| 12/23/2004 | US20040259261 quality assurance; identifying reagents on the test array, then verifying whether reagents on said test array match those reagents loaded into the microdispenser; recording the image of an entire surface of said microarray by an image-recording device to inspect the droplets |
| 12/23/2004 | US20040259259 Techniques for analyzing products containing a coloring agent |
| 12/23/2004 | US20040259256 Methods of unnatural amino acid incorporation in mammalian cells |
| 12/23/2004 | US20040259248 RNA interference mediating small RNA molecules |
| 12/23/2004 | US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference) |
| 12/23/2004 | US20040259243 using a cell line with increased sensitivity for infection for the rapid detection of enterovirus by innoculating the cells with the sample and observing; poliovirus, Coxsackie A virus, Coxsackie B virus, or echovirus; using transgenic buffalo green monkey kidney cell lines; producing enteroviruses |
| 12/23/2004 | US20040259238 filter has a physical barrier to isolate the cell sample on the filter and a growth detection circuitry associated with the filter identifies a cell growth rate using electrical measurements to detect live cells; use in microfluidics |
| 12/23/2004 | US20040259233 Optimized device for the regulation and measurement of gas content in composting platforms or platforms for the treatment of waste with measuring probes |
| 12/23/2004 | US20040259229 Novel technology for genetic mapping |
| 12/23/2004 | US20040259226 detecting the presence, absence, or amount of a Chaperonin 60 (cpn60) marker specific for one or more microbes used in bioterrorism; immunoassays and nucleic acid based assays such as fluorescence in situ hybridization (FISH); kits |
| 12/23/2004 | US20040259201 Recombinant surfactant protein D compositions and methods of use thereof |
| 12/23/2004 | US20040259189 Water supply monitoring for contaminant detection |
| 12/23/2004 | US20040259187 Methods to measure lipid antioxidant activity |
| 12/23/2004 | US20040259186 Detection of oxidizing agents in urine |
| 12/23/2004 | US20040259184 useful for identifying or quantifying TRAP in isolated osteoclast cells or osteoclasts differentiated from RAW264.7 monocyte-macrophage cells; diagnosing bone resorption disorders |
| 12/23/2004 | US20040259183 Method for measuring chemical groups attached to biological molecules |
| 12/23/2004 | US20040259182 Arrays for chemiluminescent assays, methods of making the arrays and methods of detecting chemiluminescent emissions on solid supports |
| 12/23/2004 | US20040259181 Enzyme substrates |
| 12/23/2004 | US20040259180 applying an excitation signal having a DC (direct current) component and an AC (alternating current) component; concentration of analyte is determined based on corrected DC response; accurately measuring the concentration of glucose in blood for example |
| 12/23/2004 | US20040259179 evaluating the likelihood of whether an individual will benefit from treatment with an agent for reducing risk of a future cardiovascular event, such as atherosclerosis, myocardial infarction and stroke by measuring the level of sterols |
| 12/23/2004 | US20040259178 detection of toxic substances e.g. in food packaging materials; coating a clear and flexible polymer film with a heat killed antigen, binding a horseradish peroxidase conjugated antibody thereto, adding free heat-killed antigen, washing away unbound antigen, adding tetramethylbenzidine, detecting color |
| 12/23/2004 | US20040259177 Three dimensional cell cultures in a microscale fluid handling system |
| 12/23/2004 | US20040259173 Method of determining target protein of drug |
| 12/23/2004 | US20040259172 Assay of isomerised and/or optically inverted proteins and protein fragments |
| 12/23/2004 | US20040259171 P2Y4 antibody and methods of use |
| 12/23/2004 | US20040259170 selecting phage resistant to blood inactivation using phage display library; identification of peptide-specific antibodies; peptide for complexing with a drug to protect the drug from antibody inactivation during delivery |
| 12/23/2004 | US20040259169 Methods for selection for efficient animal growth |
| 12/23/2004 | US20040259167 Isolated osteocalcin fragments |
| 12/23/2004 | US20040259165 Non-oligomerizing tandem fluorescent proteins |
| 12/23/2004 | US20040259164 Capture and release based isotope tagged peptides and methods for using the same |
| 12/23/2004 | US20040259162 container or multiwell plate for isolation of cellular components, such as polypeptides and nucleic acids, from host cells; interior surface comprising a sidewall formation and a bottom; a volume; a lytic reagent; and optionally a supported capture ligand |
| 12/23/2004 | US20040259161 functional proteomics; detect a large number of peptides while using far fewer different binders; separate to a spaced apart defined location on an array, wherein members of each class have a common motif; use to identify and diagnose disease related proteins |
| 12/23/2004 | US20040259160 drug screening for agents that induce glucose-stimulated insulin production to treat type-2 diabetes; "beta-TRP" polypeptide refers to a calcium channel; transforming islet cells with expression cassettes encoding beta-TRP into diabetic islet cells to improve glucose-stimulated insulin production |
| 12/23/2004 | US20040259159 Role of LDL receptor protein-1 (LRP-1) in Alzheimer's disease |
| 12/23/2004 | US20040259158 PYK2 and inflammation |
| 12/23/2004 | US20040259153 binding an affinity linker to a target, contacting with a replicable genetic display package (rgdp) library to bind the target substance, binding the affinity linker with a binding partner to recover the binding molecule; identifying antibodies to target antigens such as influenza virus HA protein |
| 12/23/2004 | US20040259149 uses motor protein pairs such as actin/myosin or tubulin/kinesin; one component is immobilized and the other "mobile component" is attached to a probe that specifically binds to the analyte; detecting altered velocity or cessation of the mobile component in the presence of hydrolysable nucleotide, ATP |
| 12/23/2004 | US20040259148 electrochemiluminescence (ECL) assay apparatus with ECL-inactive electrode surface having a first assay-ligand immobilized thereon and an ECL-active microparticle having a second assay ligand immobilized thereon |
| 12/23/2004 | US20040259147 Gene causative of rothmund-thomson syndrome and gene product |
| 12/23/2004 | US20040259144 calculating a prognostic index by selecting coefficients for each of a plurality of nuclear pleomorphic features using a numerical regression; prognosis of the likely time to recurrence in the patient |
| 12/23/2004 | US20040259142 Products and methods |
| 12/23/2004 | US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 12/23/2004 | US20040259138 by the influence of magnetic fields, biomolecules, covalently bound to a ferromagnetic particle by chemical, enzymatic and/or photochemically splittable crosslinkers; depositing onto microarrays, microtiter plates, test tubes |
| 12/23/2004 | US20040259136 diagnosis of arthritis based on elevated test amount of a zeta PKC gene product; drug screening, antisense agents and short interfering RNA (siRNA) |
| 12/23/2004 | US20040259134 nucleic acid of given sequence encoding glycerol kinase (GK) gene with a novel mutant allele |
| 12/23/2004 | US20040259133 precipitation ribonucleic acids by incubating with preservative in an aqueous solutions, then staining and analyzing the cells for messenger ribonucleic acid expression patterns by fluorescence in-situ hybridization |
| 12/23/2004 | US20040259131 based on interactions between proximally-bound nucleic acid tags; interaction generating at least one tag having novel sequence; reagent kit containing Mosaic Ends recognition sequences, nucleic acid tags comprise LoxP sites, Cre recombinase and Tn5 transposase |
| 12/23/2004 | US20040259124 Methods for oligonucleotide probe design |
| 12/23/2004 | US20040259119 apparatus; sequences are labelled and applied to an array of oligonucletides on at least two defined cells under hybridizing conditions; analysis of known point mutations, DNA fingerprinting, characterization of mRNAs, sequence determination; amplification not needed |
| 12/23/2004 | US20040259114 Coactivators in the diagnosis and treatment of breast cancer |
| 12/23/2004 | US20040259112 high surface-expressed vimentin in the neoplastic cell is indicative of multidrug resistance; antibody-conjugated antitumor agents targeted to multidrug resistance cancer cells; vaccines |
| 12/23/2004 | US20040259111 Once a binding assay design and sample is received from a scientist, an experiment design is automatically prepared for generating a binding-ready biological sample to be used by the binding assay such as hybrization assay; can run 24 hours a day, improving efficiency; high throughput |